Genflow Biosciences plc (LON:GENF)
London · Delayed Price · Currency is GBP · Price in GBX 1.904
-0.086 (-4.32%)
Jul 24, 2026, 3:05 PM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 10.76 million as of July 24, 2026. Its market cap has increased by 196.60% in one year.
Market Cap
10.76M
Enterprise Value
10.65M
Revenue
585.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.90
ChartMarket Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 10.76M, a decrease of -68.01%. That is a compound annual growth rate of -22.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 10.76M | 17.86% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuPharma | 24.96M |
| Arecor Therapeutics | 23.98M |
| IXICO | 18.53M |
| Aptamer Group | 15.89M |
| Fusion Antibodies | 13.44M |
| Palatin Technologies | 12.78M |
| Cizzle Biotechnology Holdings | 8.71M |
| Thalia Therapeutics | 5.83M |